• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

作者信息

Kinoshita Makoto, Yokote Koutaro, Arai Hidenori, Iida Mami, Ishigaki Yasushi, Ishibashi Shun, Umemoto Seiji, Egusa Genshi, Ohmura Hirotoshi, Okamura Tomonori, Kihara Shinji, Koba Shinji, Saito Isao, Shoji Tetsuo, Daida Hiroyuki, Tsukamoto Kazuhisa, Deguchi Juno, Dohi Seitaro, Dobashi Kazushige, Hamaguchi Hirotoshi, Hara Masumi, Hiro Takafumi, Biro Sadatoshi, Fujioka Yoshio, Maruyama Chizuko, Miyamoto Yoshihiro, Murakami Yoshitaka, Yokode Masayuki, Yoshida Hiroshi, Rakugi Hiromi, Wakatsuki Akihiko, Yamashita Shizuya

机构信息

Toray Industries, Inc.

Department of Diabetes, Metabolism and Endocrinology, Chiba University Graduate School of Medicine.

出版信息

J Atheroscler Thromb. 2018 Sep 1;25(9):846-984. doi: 10.5551/jat.GL2017. Epub 2018 Aug 22.

DOI:10.5551/jat.GL2017
PMID:30135334
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6143773/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/7f3579a59f2e/jat-25-846-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/a56d22e2578d/jat-25-846-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/f905834029c3/jat-25-846-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/f82c642cbf8e/jat-25-846-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/319406630cb0/jat-25-846-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/e8c1228bfdb2/jat-25-846-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/f11c426e8186/jat-25-846-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/7c7cee3c896c/jat-25-846-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/3db8bfca4568/jat-25-846-g008a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/02ac22206220/jat-25-846-g008b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/6a092fa6607e/jat-25-846-g008c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/210435dfc1ae/jat-25-846-g008d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/632721241c8e/jat-25-846-g008e.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/07b8f7b16fb4/jat-25-846-g008f.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/5cd2f3de09e5/jat-25-846-g008g.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/6279a8410fb7/jat-25-846-g008h.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/bc114d2855ea/jat-25-846-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/ed57e3f629b1/jat-25-846-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/a810f06c311a/jat-25-846-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/7f3579a59f2e/jat-25-846-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/a56d22e2578d/jat-25-846-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/f905834029c3/jat-25-846-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/f82c642cbf8e/jat-25-846-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/319406630cb0/jat-25-846-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/e8c1228bfdb2/jat-25-846-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/f11c426e8186/jat-25-846-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/7c7cee3c896c/jat-25-846-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/3db8bfca4568/jat-25-846-g008a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/02ac22206220/jat-25-846-g008b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/6a092fa6607e/jat-25-846-g008c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/210435dfc1ae/jat-25-846-g008d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/632721241c8e/jat-25-846-g008e.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/07b8f7b16fb4/jat-25-846-g008f.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/5cd2f3de09e5/jat-25-846-g008g.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/6279a8410fb7/jat-25-846-g008h.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/bc114d2855ea/jat-25-846-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/ed57e3f629b1/jat-25-846-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/a810f06c311a/jat-25-846-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21a8/6143773/7f3579a59f2e/jat-25-846-g012.jpg

相似文献

1
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.日本动脉粥样硬化协会（JAS）2017年动脉粥样硬化性心血管疾病预防指南。
J Atheroscler Thromb. 2018 Sep 1;25(9):846-984. doi: 10.5551/jat.GL2017. Epub 2018 Aug 22.
2
Women. Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan―2012 Version.女性。日本动脉粥样硬化协会（JAS）日本动脉粥样硬化性心血管疾病诊断与预防指南——2012版执行摘要。
J Atheroscler Thromb. 2014;21(4):291-5. doi: 10.5551/jat.19711. Epub 2013 Dec 10.
3
Treatment A) lifestyle modification: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.治疗 A）生活方式改变：日本动脉粥样硬化协会（JAS）日本动脉粥样硬化性心血管疾病诊断与预防指南（2012 版）执行摘要
J Atheroscler Thromb. 2013;20(12):835-49. doi: 10.5551/jat.18820. Epub 2013 Oct 29.
4
Comprehensive risk management for the prevention of cardiovascular disease: executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -- 2012.预防心血管疾病的综合风险管理：日本动脉粥样硬化协会（JAS）日本动脉粥样硬化性心血管疾病诊断与预防指南——2012年执行摘要
J Atheroscler Thromb. 2013;20(7):603-15. doi: 10.5551/jat.15867. Epub 2013 Jul 25.
5
Treatment B) drug therapy: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.治疗B）药物治疗：日本动脉粥样硬化协会（JAS）关于日本动脉粥样硬化性心血管疾病诊断与预防指南——2012版执行摘要
J Atheroscler Thromb. 2013;20(12):850-60. doi: 10.5551/jat.19166. Epub 2013 Dec 10.
6
Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version.日本动脉粥样硬化协会（JAS）日本动脉粥样硬化性心血管疾病诊断与预防指南2012版执行摘要
J Atheroscler Thromb. 2013;20(6):517-23. doi: 10.5551/jat.15792. Epub 2013 May 11.
7
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022.日本动脉粥样硬化协会（JAS）2022年动脉粥样硬化性心血管疾病预防指南。
J Atheroscler Thromb. 2024 Jun 1;31(6):641-853. doi: 10.5551/jat.GL2022. Epub 2023 Dec 19.
8
Diabetes mellitus. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.糖尿病。日本动脉粥样硬化协会（JAS）关于日本动脉粥样硬化性心血管疾病诊断与预防指南——2012版执行摘要。
J Atheroscler Thromb. 2014;21(2):93-8. doi: 10.5551/jat.19349. Epub 2013 Dec 10.
9
Coronary artery disease. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.冠状动脉疾病。日本动脉粥样硬化协会（JAS）日本动脉粥样硬化性心血管疾病诊断与预防指南——2012版执行摘要。
J Atheroscler Thromb. 2014;21(2):86-92. doi: 10.5551/jat.19158. Epub 2013 Dec 10.
10
Other types of primary hyperlipoproteinemia(hyperlipidemia). Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.其他类型的原发性高脂蛋白血症（高脂血症）。日本动脉粥样硬化协会（JAS）关于日本动脉粥样硬化性心血管疾病诊断和预防指南的执行摘要——2012年版。
J Atheroscler Thromb. 2014;21(2):82-5. doi: 10.5551/jat.19141. Epub 2013 Dec 10.

引用本文的文献

1
Network Medicine-Based Repurposing of Mesalazine for Atherosclerosis Treatment.基于网络医学的美沙拉嗪用于动脉粥样硬化治疗的药物重新利用
J Cardiovasc Transl Res. 2025 Sep 10. doi: 10.1007/s12265-025-10637-8.
2
Relationships between metabolic syndrome and lifestyle factors: a retrospective cohort study in Japan.代谢综合征与生活方式因素之间的关系：一项日本的回顾性队列研究。
Prev Med Rep. 2025 Aug 5;57:103195. doi: 10.1016/j.pmedr.2025.103195. eCollection 2025 Sep.
3
Assessing the impact of aggressive versus intermediate LDL-C goal achievement in Asian adults: a retrospective cohort study using national health insurance service-senior cohort.

本文引用的文献

1
Retraction and Republication: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet. N Engl J Med 2013;368:1279-90.撤稿与重新发表：地中海饮食对心血管疾病的一级预防。《新英格兰医学杂志》2013年；368卷：1279 - 1290页。
N Engl J Med. 2018 Jun 21;378(25):2441-2442. doi: 10.1056/NEJMc1806491. Epub 2018 Jun 13.
2
Guidance for Pediatric Familial Hypercholesterolemia 2017.2017 年儿童家族性高胆固醇血症治疗指南
J Atheroscler Thromb. 2018 Jun 1;25(6):539-553. doi: 10.5551/jat.CR002. Epub 2018 Feb 6.
3
Comprehensive Risk Management for the Prevention of Cerebro- Cardiovascular Diseases in Japan.
评估亚洲成年人中积极与中等低密度脂蛋白胆固醇（LDL-C）目标达成情况的影响：一项使用国民健康保险服务老年队列的回顾性队列研究。
Lipids Health Dis. 2025 Aug 8;24(1):259. doi: 10.1186/s12944-025-02677-5.
4
The Chronic Effect of Stair Climbing-Descending Exercises after Meals on Glycemic Control in Individuals with Type 2 Diabetes: A Randomized Controlled Trial.餐后爬楼梯-下楼梯运动对2型糖尿病患者血糖控制的长期影响：一项随机对照试验
Muscles. 2023 Jun 15;2(2):238-249. doi: 10.3390/muscles2020018.
5
Association of remnant cholesterol with new-onset hypertension among middle-aged and older adults in China.中国中老年人群中残余胆固醇与新发高血压的关联。
Sci Rep. 2025 Jul 13;15(1):25296. doi: 10.1038/s41598-025-09678-5.
6
Data-driven prediction of cardiovascular and cerebrovascular diseases in a nationwide study.一项全国性研究中基于数据驱动的心血管和脑血管疾病预测
Sci Rep. 2025 Jul 2;15(1):22585. doi: 10.1038/s41598-025-94888-0.
7
Efficacy and safety of pemafibrate administration in patients with dyslipidemia: a systematic review and updated meta-analysis of randomized controlled trials.佩马贝特治疗血脂异常患者的疗效和安全性：一项随机对照试验的系统评价和更新的荟萃分析
Ann Med Surg (Lond). 2025 Apr 22;87(6):3756-3767. doi: 10.1097/MS9.0000000000003264. eCollection 2025 Jun.
8
Out-of-distribution reject option method for dataset shift problem in early disease onset prediction.早期疾病发病预测中数据集偏移问题的分布外拒绝选项方法
Sci Rep. 2025 Jun 2;15(1):19240. doi: 10.1038/s41598-025-01811-8.
9
White Matter Microstructure Alterations in Older Adults With Dyslipidemia Associated With Cognitive and Locomotor Dysfunction Evaluated Using Neurite Orientation Dispersion and Density Imaging.使用神经突方向离散度与密度成像评估血脂异常的老年人白质微结构改变与认知和运动功能障碍的相关性
Brain Behav. 2025 Jun;15(6):e70526. doi: 10.1002/brb3.70526.
10
Development and validation of a nomogram for in-stent restenosis within 2 years in patients after iliac or femoral artery stent placement.髂动脉或股动脉支架置入术后患者2年内支架内再狭窄预测模型的建立与验证
BMC Surg. 2025 May 21;25(1):221. doi: 10.1186/s12893-025-02955-0.
日本预防心脑血管疾病的综合风险管理
J Atheroscler Thromb. 2017 Jul 1;24(7):749-764. doi: 10.5551/jat.CR001. Epub 2017 Jun 23.
4
Brachial-Ankle Pulse Wave Velocity and the Risk Prediction of Cardiovascular Disease: An Individual Participant Data Meta-Analysis.肱踝脉搏波速度与心血管疾病风险预测的个体参与者数据荟萃分析。
Hypertension. 2017 Jun;69(6):1045-1052. doi: 10.1161/HYPERTENSIONAHA.117.09097. Epub 2017 Apr 24.
5
Causes of death in Japanese patients with diabetes based on the results of a survey of 45,708 cases during 2001-2010: Report of the Committee on Causes of Death in Diabetes Mellitus.基于2001 - 2010年45708例患者的调查结果分析日本糖尿病患者的死因：糖尿病死因委员会报告
J Diabetes Investig. 2017 May;8(3):397-410. doi: 10.1111/jdi.12645. Epub 2017 Mar 27.
6
Homogeneous Assays for LDL-C and HDL-C are Reliable in Both the Postprandial and Fasting State.低密度脂蛋白胆固醇（LDL-C）和高密度脂蛋白胆固醇（HDL-C）的均相测定法在餐后和空腹状态下均可靠。
J Atheroscler Thromb. 2017 Jun 1;24(6):583-599. doi: 10.5551/jat.40006. Epub 2017 Mar 17.
7
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.依洛尤单抗与心血管疾病患者的临床结局。
N Engl J Med. 2017 May 4;376(18):1713-1722. doi: 10.1056/NEJMoa1615664. Epub 2017 Mar 17.
8
Efficacy and Safety of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia.洛美他派在日本纯合子家族性高胆固醇血症患者中的疗效与安全性
J Atheroscler Thromb. 2017 Apr 3;24(4):402-411. doi: 10.5551/jat.38216. Epub 2017 Feb 2.
9
Fibrates for primary prevention of cardiovascular disease events.贝特类药物用于心血管疾病事件的一级预防。
Cochrane Database Syst Rev. 2016 Nov 16;11(11):CD009753. doi: 10.1002/14651858.CD009753.pub2.
10
Impact of glucose tolerance status on the development of coronary artery disease among working-age men.糖耐量状态对在职男性冠心病发病的影响。
Diabetes Metab. 2017 Jun;43(3):261-264. doi: 10.1016/j.diabet.2016.09.001. Epub 2016 Oct 4.